These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 16177635

  • 1. Posttransplant lymphoproliferative disorder in pancreas transplantation: a single-center experience.
    Paraskevas S, Coad JE, Gruessner A, Kandaswamy R, Humar A, Sutherland DE, Gruessner RW.
    Transplantation; 2005 Sep 15; 80(5):613-22. PubMed ID: 16177635
    [Abstract] [Full Text] [Related]

  • 2. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
    Hsu CT, Chang MH, Ho MC, Chang HH, Lu MY, Jou ST, Ni YH, Chen HL, Hsu HY, Wu JF.
    J Formos Med Assoc; 2019 Nov 15; 118(11):1537-1545. PubMed ID: 30630698
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
    Khedmat H, Taheri S.
    Exp Clin Transplant; 2012 Apr 15; 10(2):141-7. PubMed ID: 22432758
    [Abstract] [Full Text] [Related]

  • 4. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL.
    Clin Transplant; 1995 Feb 15; 9(1):53-9. PubMed ID: 7742583
    [Abstract] [Full Text] [Related]

  • 5. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 15; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 6. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients.
    Liu M, Husain S, Famure O, Li Y, Kim SJ.
    Prog Transplant; 2019 Jun 15; 29(2):185-193. PubMed ID: 30845885
    [Abstract] [Full Text] [Related]

  • 7. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ.
    Transplantation; 2017 Mar 15; 101(3):657-663. PubMed ID: 27214265
    [Abstract] [Full Text] [Related]

  • 8. Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients.
    L'Huillier AG, Dipchand AI, Ng VL, Hebert D, Avitzur Y, Solomon M, Ngan BY, Yeung S, Stephens D, Punnett AS, Barton M, Allen UD.
    Transplantation; 2019 Nov 15; 103(11):e369-e374. PubMed ID: 31385930
    [Abstract] [Full Text] [Related]

  • 9. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun 15; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 10. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Jun 15; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 11. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK.
    Transplantation; 2018 Sep 15; 102(9):1553-1562. PubMed ID: 29485513
    [Abstract] [Full Text] [Related]

  • 12. Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort.
    Huang JG, Tan MYQ, Quak SH, Aw MM.
    Transpl Infect Dis; 2018 Feb 15; 20(1):. PubMed ID: 29071779
    [Abstract] [Full Text] [Related]

  • 13. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.
    Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, Crouch J, Bia MJ, Kliger AS, Lorber MI.
    Transplantation; 1997 Sep 27; 64(6):848-52. PubMed ID: 9326409
    [Abstract] [Full Text] [Related]

  • 14. Posttransplant lymphoproliferative disorder following pancreas transplantation.
    Issa N, Amer H, Dean PG, Kremers WK, Kudva YC, Rostambeigi N, Cosio FG, Larson TS, Habermann TM, Stegall MD, Griffin MD.
    Am J Transplant; 2009 Aug 27; 9(8):1894-902. PubMed ID: 19519812
    [Abstract] [Full Text] [Related]

  • 15. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov 27; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 16. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Nephrol Dial Transplant; 2012 Jul 27; 27(7):2971-9. PubMed ID: 22273720
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.
    Morton M, Coupes B, Roberts SA, Klapper PE, Byers RJ, Vallely PJ, Ryan K, Picton ML.
    Transplantation; 2013 Feb 15; 95(3):470-8. PubMed ID: 23222821
    [Abstract] [Full Text] [Related]

  • 18. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N, Büchler M, Foucher Y, Moreau A, Debiais C, Machet MC, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J.
    Transpl Int; 2014 Sep 15; 27(9):956-65. PubMed ID: 24964147
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 20. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.
    Chest; 2004 Dec 27; 126(6):2013-20. PubMed ID: 15596707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.